U.S. FDA advisors set to review opioid constipation drugs
June 09, 2014 at 10:35 AM EDT
June 9 (Reuters) - U.S. Food and Drug Administration advisers are set to vote this week on whether more clinical trials are needed to assess cardiovascular risk in a class of drugs used to treat opioid-induced chronic constipation.
